Emtricitabine Terminated Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections / HBV Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT02556333Emtricitabine/Tenofovir Alafenamide as Salvage ART
NCT02116660Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
NCT00090779Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV
NCT00768989Phase IIB Pilot of Atazanavir + Raltegravir